Form 8-K - Current report:
SEC Accession No. 0001104659-24-131723
Filing Date
2024-12-26
Accepted
2024-12-26 16:29:14
Documents
15
Period of Report
2024-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2432020d2_8k.htm   iXBRL 8-K 24771
2 EXHIBIT 99.1 tm2432020d2_ex99-1.htm EX-99.1 10603
6 GRAPHIC tm2432020d2_ex99-1img001.jpg GRAPHIC 9914
  Complete submission text file 0001104659-24-131723.txt   224614

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20241219.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20241219_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20241219_pre.xml EX-101.PRE 22353
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2432020d2_8k_htm.xml XML 3584
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 241581363
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)